Page last updated: 2024-08-25

eletriptan and Migraine Disorders

eletriptan has been researched along with Migraine Disorders in 109 studies

Research

Studies (109)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (1.83)	18.2507
2000's	91 (83.49)	29.6817
2010's	14 (12.84)	24.3611
2020's	2 (1.83)	2.80

Authors

Authors	Studies
Bell, IM	1
Björklund, S; Dahlström, B; Doko, A; Engblom, J; Eskandari, M; Feiler, A; Prgomet, Z; Riaz, A; Rönn, R; Sultana, K; Valetti, S	1
Amundsen, S; Fuskevåg, OM; Nordeng, H; Nordmo, E; Sager, G; Spigset, O	1
Baradia, D; Dobaria, N; Ghoghari, A; Laddha, R; Mehta, P; Modi, N; Patel, H; Patel, P; Shah, S; Srinivas, NR; Variya, B	1
Diener, H-	1
Chae, D; Park, K	1
Almas, M; Landy, S; Ramos, E; Schweizer, E; Tepper, SJ	1
Abdulsattar, Y; Almas, M; Bhambri, R; Chatterjee, A; Martin, VT; Ramos, E; Silberstein, S	1
Almas, M; Landy, SH; Ramos, E; Schweizer, E; Tepper, SJ	1
Kitagawa, Y; Suzuki, Y; Takayanagi, R; Tokuoka, K; Watanabe, M; Yamada, Y	1
Han, W; Li, M; Wang, J; Xu, H	1
DelGaudio, JM; Kari, E	1
Krishnan, H; Ravikumar, K; Singh, AN; Sridhar, B	1
Busschbach, JJ; Couturier, EG; Mérelle, SY; Passchier, J; van Bokhorst, J	1
Nappi, G; Perrotta, A; Sandrini, G; Tassorelli, C	1
Autret-Leca, E; Beau-Salinas, F; Bensouda-Grimaldi, L; Cissoko, H; Jonville-Béra, AP	1
Bernstein, CD; Marcus, DA; Rudy, TE; Sullivan, EA	1
Farkasova, D; Marcek, T; Turcani, M; Turcani, P	1
Barbanti, P; Dahlöf, C; Diener, HC; Habeck, J; Podhorna, J; Reuter, U	1
Frith, AA; Hackshaw, A; MacGregor, EA	1
Rapoport, AM; Sheftell, FD; Tepper, SJ	1
Boers, PM; Donaldson, C; Hoskin, KL; Lambert, GA; Zagami, AS	1
Burgess, G; Färkkilä, M; Forster, E; Haughie, S; Sandrini, G	1
Giffin, N	1
Pitman, V; Ryan, R; Sheftell, F	1
Mathew, NT; Muirhead, N; Schoenen, J; Sikes, CR; Winner, P	1
Deleu, D; Hanssens, Y	3
Adelman, JU; Lewit, EJ	1
Dahlöf, C; Färkkilä, M; Muirhead, N; Olesen, J; Rasmussen, S; Sikes, C; Stovner, LJ; ter Bruggen, JP	1
Omote, M	1
Dodick, DW	1
Ashkenazi, A; Silberstein, SD	1
Loftus, BD	1
Alderman, J; Hettiarachchi, J; Mathew, NT	1
Cheong, YM; Chia, YC; Denaro, J; Hettiarachchi, J; Lim, SH; Wang, SJ	1
Kaniecki, RG	1
Bordini, CA; Garcia-Ramos, G; Hettiarachchi, J; Hilliard, B; Leston, J; MacGregor, EA	1
Diener, HC; Hettiarachchi, J; Ryan, R; Sun, W	1
Hussar, DA	1
Diener, HC; MacGregor, EA; Muirheads, N; Schoenen, J; Sikes, CR; Steiner, TJ	1
Iizuka, T; Sakai, F	1
Diamond, ML; Hettiarachchi, J; Hilliard, B; Nett, R; Sands, G	1
Diener, HC; Poole, P; Ryan, R; Sakai, F	1
Bigal, ME; Goadsby, PJ; Lipton, RB	1
Dodick, DW; Ferrari, MD; Goadsby, PJ; McCrory, DC; Williams, P	1
Diener, HC; Hettiarachchi, J; Olesen, J; Schoenen, J	1
Díez-Tejedor, E; Ezpeleta, D; Jiménez, D; Lainez, JM; Leira, R; Liaño, H; Madrigal, M; Mateos, V; Navarro, A; Palacios, G; Pascual, J	1
Kato, K	1
Manaka, S	1
Kowa, H; Nakashima, K; Takeshima, T	1
Igarashi, H	1
Morillo, LE	2
Hettiarachchi, J; Pascual, J; Rasmussen, S; Schoenen, J; Sikes, C; Sun, W	1
Diener, HC	1
Healey, PJ; Mullins, CD; Perfetto, EM; Subedi, PR; Weis, KA	1
Färkkilä, M; Kallela, M	1
Capuano, A; Di Trapani, G; Evangelista, M; Ferraro, D; Mei, D; Pierguidi, L; Vollono, C	1
Alderman, J; Cox, E; Mandema, JW	1
Almas, M; Hilliard, B; Loder, E; Martin, VT; Taylor, K	1
Brandes, JL; Cady, R; Kudrow, D; Sikes, CR; Sun, W; Tiseo, PJ	1
Allais, G; Allen, C; Evers, S; Kinge, E; Láinez, MJ; Lis, K; Massaad, R; Rao, NA	1
Auvin, S; Cuvellier, JC; Joriot, S; Vallée, L	1
Kamath, V; Piccininni, LC; Takiya, L	1
Mullins, CD; Pradel, FG; Subedi, P; Varghese, AA; Weis, KA	1
Iversen, HK; Tfelt-Hansen, P	1
Keating, GM; McCormack, PL	2
Almas, M; Elkind, A; Mulhern, SA; Olson, N; Sikes, C; Sunshine, A	1
Nappi, G; Perrotta, A; Sandrini, G	1
Hustad, CM; Ramsey, KE; Rodgers, A; Skobieranda, F	1
Almas, M; Linder, SL; Lipton, RB; Parsons, B; Pitman, V; Winner, P	1
Albert, KS; Almas, M; Cady, RK; Parsons, B; Sheftell, FD; Silberstein, SD	1
Almas, M; Nett, RB; Sikes, CR; Tiseo, PJ	1
Almas, M; Diener, HC; Dodick, DW; Goadsby, PJ; Lipton, RB; Parsons, B	1
Albert, KS; Almas, M; Diener, HC; Dodick, DW; Ferrari, MD; Goadsby, PJ; Lipton, RB; Parsons, B; Tfelt-Hansen, P	1
Nahas, SJ; Silberstein, SD	1
De Vries, P; Heiligers, JP; Saxena, PR; Willems, E	1
Baulieu, J; Fabre, JM; Hyland, R; Maurel, P; Milton, A; Pichard-Garcia, L	1
Ferrari, MD; Goadsby, PJ; Jackson, NC; Olesen, J; Poole, PH; Senard, JM; Stovner, LJ	1
Palmer, JB; Salonen, R	1
Spierings, EL	1
Al-Shekhlee, A; Reed, R	1
Chadaide, Z; Csillik, AE; Knyihár-Csillik, E; Mihály, A; Tajti, J; Vécsei, L	1
Diener, HC; McHarg, A	1
Steiner, TJ; Wells, NE	1
Chadaide, Z; Csillik, B; Knyihár-Csillik, E; Tajti, J; Vécsei, L	1
Hashimoto, S; Iwata, M	1
Marcus, DA	1
Allen, C	1
Einecke, D	1
McQuay, HJ; Moore, RA; Oldman, AD; Smith, LA	1
Ferrari, MD; Goadsby, PJ; Lipton, RB; Roon, KI	1
Gawel, MJ; Grujich, NN	1
Diener, HC; Jansen, JP; Pascual, J; Pitei, D; Reches, A; Steiner, TJ	1
Freitag, FG	1
Dahlöf, C; Haughie, S; Hettiarachchi, J; Stark, R	1

Reviews

36 review(s) available for eletriptan and Migraine Disorders

Article	Year
Calcitonin gene-related peptide receptor antagonists: new therapeutic agents for migraine. Journal of medicinal chemistry, 2014, Oct-09, Volume: 57, Issue:19 Topics: Amino Acid Sequence; Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Drug Discovery; Humans; Migraine Disorders; Molecular Sequence Data; Receptors, Calcitonin Gene-Related Peptide; Structure-Activity Relationship	2014
MMW Fortschritte der Medizin, 2017, Volume: 159, Issue:18 Topics: Analgesics; Aspirin; Diclofenac; Humans; Ibuprofen; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Tryptamines	2017
Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials. Headache, 2014, Volume: 54, Issue:2 Topics: Adult; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Female; Humans; Logistic Models; Menstruation; Middle Aged; Migraine Disorders; Outcome Assessment, Health Care; Pyrrolidines; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	2014
Network meta-analysis of migraine disorder treatment by NSAIDs and triptans. The journal of headache and pain, 2016, Volume: 17, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Ibuprofen; Migraine Disorders; Oxazolidinones; Pyrrolidines; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines	2016
Eletriptan. Expert opinion on drug metabolism & toxicology, 2009, Volume: 5, Issue:12 Topics: Animals; Controlled Clinical Trials as Topic; Humans; Migraine Disorders; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Tryptamines	2009
Mechanisms of action of the 5-HT1B/1D receptor agonists. Archives of neurology, 2002, Volume: 59, Issue:7 Topics: Carbazoles; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2002
Eletriptan: pharmacological differences and clinical results. Current medical research and opinion, 2001, Volume: 17 Suppl 1 Topics: Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2001
Comparative aspects of triptans in treating migraine. Clinical cornerstone, 2001, Volume: 4, Issue:3 Topics: Carbazoles; Cardiovascular Diseases; Humans; Indoles; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines	2001
[Pharmacological, pharmacokinetic and clinical profile of eletriptan (Relpax), a new triptan for migraine]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003, Volume: 122, Issue:1 Topics: Administration, Oral; Animals; Capillary Permeability; Humans; Indoles; Migraine Disorders; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin Receptor Agonists; Skull; Trigeminal Nerve; Tryptamines; Vasoconstriction	2003
Sumatriptan versus eletriptan: which is best? The Lancet. Neurology, 2002, Volume: 1, Issue:8 Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Tryptamines	2002
The evolving management of migraine. Current opinion in neurology, 2003, Volume: 16, Issue:3 Topics: Angiotensin Receptor Antagonists; Anticonvulsants; Antipsychotic Agents; Botulinum Toxins, Type A; Carbazoles; Droperidol; Fructose; Humans; Indoles; Migraine Disorders; Neuromuscular Agents; Oxazolidinones; Pyrrolidines; Serotonin Receptor Agonists; Topiramate; Tryptamines	2003
Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review. Headache, 2003, Volume: 43, Issue:9 Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Indoles; Male; Meta-Analysis as Topic; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Tryptamines	2003
[Recent progress in therapy for migraine headache]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2004, Feb-10, Volume: 93, Issue:2 Topics: Anticonvulsants; Botulinum Toxins; Calcitonin Gene-Related Peptide; Central Nervous System; Clinical Trials as Topic; Drug Design; Fructose; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Pain; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Signal Transduction; Sumatriptan; Topiramate; Triazoles; Trigeminal Nerve; Tryptamines; Vasodilation	2004
Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalalgia : an international journal of headache, 2004, Volume: 24, Issue:5 Topics: Administration, Oral; Analgesics; Double-Blind Method; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pyrrolidines; Randomized Controlled Trials as Topic; Sumatriptan; Tryptamines	2004
[Triptans in migraine: a comparative review of pharmacology, pharmacokinetics]. No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:9 Topics: Animals; Biological Availability; Cardiovascular System; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2004
[Triptans in migraine: from clinical view]. No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:9 Topics: Drug Administration Schedule; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2004
[Meta-analysis of triptan treatment in migraine]. No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:9 Topics: Carbazoles; Evidence-Based Medicine; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2004
[Side effects of triptans]. No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:9 Topics: Central Nervous System; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Nausea; Oxazolidinones; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sleep Stages; Sumatriptan; Triazoles; Tryptamines; Vomiting	2004
Migraine headache. Clinical evidence, 2003, Issue:10 Topics: Acute Disease; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Child; Diclofenac; Drug Therapy, Combination; Ergotamine; Humans; Ibuprofen; Indoles; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Oxazolidinones; Piperidines; Pyrrolidines; Salicylates; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2003
Migraine headache. Clinical evidence, 2004, Issue:11 Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Ergotamine; Humans; Ibuprofen; Indoles; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Oxazolidinones; Piperidines; Pyrrolidines; Salicylates; Sumatriptan; Triazoles; Tryptamines	2004
Eletriptan in migraine. Expert review of neurotherapeutics, 2005, Volume: 5, Issue:1 Topics: Analgesics; Drug Interactions; Economics, Pharmaceutical; Expert Testimony; Humans; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Tryptamines	2005
Eletriptan review. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:4 Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Tryptamines	2005
Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation. Cephalalgia : an international journal of headache, 2005, Volume: 25, Issue:9 Topics: Capsules; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Models, Statistical; Pyrrolidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2005
Safety and efficacy of eletriptan in the treatment of acute migraine. Pharmacotherapy, 2006, Volume: 26, Issue:1 Topics: Acute Disease; Clinical Trials as Topic; Drug Interactions; Humans; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Tryptamines	2006
[Triptanes in the treatment of migraine. A review based on three Cochrane reviews]. Ugeskrift for laeger, 2006, May-08, Volume: 168, Issue:19 Topics: Acute Disease; Administration, Oral; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2006
Eletriptan: a review of its use in the acute treatment of migraine. Drugs, 2006, Volume: 66, Issue:8 Topics: Animals; Humans; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Tryptamines	2006
Spotlight on eletriptan in migraine. CNS drugs, 2006, Volume: 20, Issue:11 Topics: Humans; Migraine Disorders; Pyrrolidines; Receptors, Serotonin; Serotonin Receptor Agonists; Tryptamines	2006
Eletriptan: a review and new perspectives. Expert review of neurotherapeutics, 2006, Volume: 6, Issue:10 Topics: Animals; Humans; Migraine Disorders; Pyrrolidines; Tryptamines	2006
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents. Acta neurologica Belgica, 1999, Volume: 99, Issue:2 Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Design; Drug Interactions; Humans; Inactivation, Metabolic; Indoles; Meninges; Migraine Disorders; Molecular Structure; Nociceptors; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Pyrrolidines; Randomized Controlled Trials as Topic; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recurrence; Serotonin Receptor Agonists; Structure-Activity Relationship; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents	1999
Current and emerging second-generation triptans in acute migraine therapy: a comparative review. Journal of clinical pharmacology, 2000, Volume: 40, Issue:7 Topics: Acute Disease; Carbazoles; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines	2000
[Current topics: expectation for new triptans]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2001, Apr-10, Volume: 90, Issue:4 Topics: Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2001
Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans). Archives of neurology, 2001, Volume: 58, Issue:7 Topics: Analgesics, Non-Narcotic; Carbazoles; Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pain Measurement; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Triazoles; Tryptamines	2001
Eletriptan for acute migraine. The Cochrane database of systematic reviews, 2001, Issue:3 Topics: Acute Disease; Clinical Trials, Phase III as Topic; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Tryptamines	2001
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (London, England), 2001, Nov-17, Volume: 358, Issue:9294 Topics: Acute Disease; Administration, Oral; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Triazoles; Tryptamines	2001
Eletriptan. Expert opinion on investigational drugs, 2001, Volume: 10, Issue:10 Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Tryptamines	2001
Acute treatment of migraine and the role of triptans. Current neurology and neuroscience reports, 2001, Volume: 1, Issue:2 Topics: Acute Disease; Blood Flow Velocity; Carbazoles; Clinical Trials as Topic; Drug Administration Routes; Female; Humans; Indoles; Male; Menstruation; Migraine Disorders; Oxazolidinones; Piperidines; Practice Guidelines as Topic; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents	2001

Trials

33 trial(s) available for eletriptan and Migraine Disorders

Article	Year
An item response theory based integrated model of headache, nausea, photophobia, and phonophobia in migraine patients. Journal of pharmacokinetics and pharmacodynamics, 2018, Volume: 45, Issue:5 Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Headache; Humans; Hyperacusis; Male; Middle Aged; Migraine Disorders; Nausea; Photophobia; Pyrrolidines; Tryptamines; Young Adult	2018
Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study. Cephalalgia : an international journal of headache, 2014, Volume: 34, Issue:2 Topics: Adolescent; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Placebos; Pyrrolidines; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Young Adult	2014
Theory-based analysis of clinical efficacy of triptans using receptor occupancy. The journal of headache and pain, 2014, Dec-08, Volume: 15 Topics: Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines	2014
Large-scale screening and subsequent effects of migraine treatment on the work floor in the Netherlands. Cephalalgia : an international journal of headache, 2009, Volume: 29, Issue:6 Topics: Adult; Cross-Over Studies; Efficiency; Female; Humans; Male; Mass Screening; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Quality of Life; Serotonin Receptor Agonists; Tryptamines	2009
Perimenstrual eletriptan prevents menstrual migraine: an open-label study. Headache, 2010, Volume: 50, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Comorbidity; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Medical Records; Menstruation Disturbances; Middle Aged; Migraine Disorders; Pain Measurement; Premenstrual Syndrome; Prospective Studies; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Tryptamines; Young Adult	2010
Real-life experiences in migraine therapy. Bratislavske lekarske listy, 2010, Volume: 111, Issue:2 Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Preference; Pyrrolidines; Serotonin Receptor Agonists; Tryptamines; Young Adult	2010
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study. Cephalalgia : an international journal of headache, 2011, Volume: 31, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Analgesics; Calcitonin Gene-Related Peptide; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Pyrrolidines; Tryptamines; Young Adult	2011
Efficacy, safety, and tolerability of sertraline on depressive symptoms in women with comorbid migraine: an open-label study. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:3 Topics: Adult; Depression; Female; Humans; Middle Aged; Migraine Disorders; Pyrrolidines; Quality of Life; Selective Serotonin Reuptake Inhibitors; Self Report; Serotonin Receptor Agonists; Sertraline; Tryptamines	2011
Efficacy and safety of eletriptan 20 mg, 40 mg and 80 mg in Japanese migraineurs. Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Japan; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Prospective Studies; Pyrrolidines; Recurrence; Saliva; Treatment Outcome; Tryptamines	2002
Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study. Neurology, 2002, Oct-22, Volume: 59, Issue:8 Topics: Adult; Double-Blind Method; Female; Humans; Indoles; Logistic Models; Male; Middle Aged; Migraine Disorders; Pyrrolidines; Remission Induction; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2002
Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: a multicenter, double-blind, placebo-controlled study conducted in the United States. Headache, 2003, Volume: 43, Issue:3 Topics: Acute Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Male; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines; United States	2003
Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg. Headache, 2003, Volume: 43, Issue:3 Topics: Acute Disease; Adolescent; Adult; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2003
Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia : an international journal of headache, 2003, Volume: 23, Issue:6 Topics: Administration, Oral; Adult; Aged; Double-Blind Method; Drug Tolerance; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Pyrrolidines; Sumatriptan; Tryptamines	2003
Efficacy of eletriptan in migraineurs with persistent poor response to nonsteroidal anti-inflammatory drugs. Headache, 2003, Volume: 43, Issue:9 Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2003
Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine. Cephalalgia : an international journal of headache, 2003, Volume: 23, Issue:9 Topics: Adult; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	2003
Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine. Cephalalgia : an international journal of headache, 2003, Volume: 23, Issue:10 Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Linear Models; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pyrrolidines; Tryptamines	2003
Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders. Headache, 2004, Volume: 44, Issue:3 Topics: Acute Disease; Adolescent; Adult; Analgesics, Non-Narcotic; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Nonprescription Drugs; Pyrrolidines; Serotonin Receptor Agonists; Treatment Failure; Tryptamines	2004
Eletriptan for the acute treatment of migraine: results of bridging a Japanese study to Western clinical trials. Current medical research and opinion, 2004, Volume: 20, Issue:3 Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Australia; Clinical Trials as Topic; Double-Blind Method; Europe; Female; Humans; Indoles; Japan; Male; Middle Aged; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; United States	2004
No effect of eletriptan administration during the aura phase of migraine. European journal of neurology, 2004, Volume: 11, Issue:10 Topics: Adult; Aged; Case-Control Studies; Double-Blind Method; Epilepsy; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	2004
Patient preference for eletriptan 80 mg versus subcutaneous sumatriptan 6 mg: results of a crossover study in patients who have recently used subcutaneous sumatriptan. European journal of neurology, 2005, Volume: 12, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Cross-Over Studies; Female; Humans; Indoles; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2005
Multiple attack study on the available triptans in Italy versus placebo. European journal of neurology, 2005, Volume: 12, Issue:7 Topics: Adult; Female; Humans; Indoles; Italy; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines	2005
Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study. Cephalalgia : an international journal of headache, 2005, Volume: 25, Issue:9 Topics: Acetaminophen; Adolescent; Adult; Analgesics; Aspirin; Barbiturates; Caffeine; Drug Combinations; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Quality of Life; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2005
Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing. Cephalalgia : an international journal of headache, 2005, Volume: 25, Issue:9 Topics: Adolescent; Adult; Aged; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Pain; Pyrrolidines; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	2005
Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine. Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Serotonin Receptor Agonists; Tablets; Time Factors; Triazoles; Tryptamines	2006
Does earlier headache response equate to earlier return to functioning in patients suffering from migraine? Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Comorbidity; Double-Blind Method; Female; Headache; Humans; Incidence; Male; Maryland; Middle Aged; Migraine Disorders; Outcome Assessment, Health Care; Patient Satisfaction; Pyrrolidines; Recovery of Function; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2006
Comparative sensitivity of stopwatch methodology and conventional pain assessment measures for detecting early response to triptans in migraine: results of a randomized, open-label pilot study. Clinical therapeutics, 2006, Volume: 28, Issue:8 Topics: Adult; Analysis of Variance; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Pilot Projects; Pyrrolidines; Serotonin Receptor Agonists; Triazoles; Tryptamines	2006
Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial. Headache, 2007, Volume: 47, Issue:4 Topics: Adolescent; Age Factors; Child; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Placebos; Pyrrolidines; Secondary Prevention; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	2007
Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes. Headache, 2007, Volume: 47, Issue:5 Topics: Adult; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Outpatients; Pyrrolidines; Serotonin Receptor Agonists; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Tryptamines; Work Capacity Evaluation; Workload	2007
Human hepatocytes in primary culture predict lack of cytochrome P-450 3A4 induction by eletriptan in vivo. Drug metabolism and disposition: the biological fate of chemicals, 2000, Volume: 28, Issue:1 Topics: Adult; Aged; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA Fragmentation; DNA Primers; Enzyme Induction; Female; Humans; Hydrocortisone; Indoles; Liver; Male; Microsomes, Liver; Middle Aged; Migraine Disorders; Mixed Function Oxygenases; Pyrrolidines; Serotonin Receptor Agonists; Tryptamines	2000
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology, 2000, Jan-11, Volume: 54, Issue:1 Topics: Acute Disease; Administration, Oral; Adult; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Placebos; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines; Vasoconstrictor Agents	2000
Effectiveness of eletriptan in reducing time loss caused by migraine attacks. PharmacoEconomics, 2000, Volume: 18, Issue:6 Topics: Adult; Female; Humans; Indoles; Male; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Tryptamines	2000
Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. European neurology, 2002, Volume: 47, Issue:2 Topics: Adolescent; Adult; Aged; Caffeine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ergotamine; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2002
Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks. Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Pain Measurement; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2002

Other Studies

40 other study(ies) available for eletriptan and Migraine Disorders

Article	Year
Oral transmucosal delivery of eletriptan for neurological diseases. International journal of pharmaceutics, 2022, Nov-05, Volume: 627 Topics: Administration, Oral; Dimethyl Sulfoxide; Humans; Migraine Disorders; Pharmaceutical Preparations; Phospholipids; Quality of Life; Tryptamines	2022
Transfer of triptans into human breast milk and estimation of infant drug exposure through breastfeeding. Basic & clinical pharmacology & toxicology, 2021, Volume: 128, Issue:6 Topics: Adult; Breast Feeding; Female; Humans; Infant; Infant, Newborn; Migraine Disorders; Milk, Human; Oxazolidinones; Piperidines; Pyrrolidines; Triazoles; Tryptamines	2021
One should avoid retro-orbital pharmacokinetic sample collections for intranasal dosing in rats: Illustration of spurious pharmacokinetics generated for anti-migraine drugs zolmitriptan and eletriptan. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2017, Aug-30, Volume: 106 Topics: Administration, Intranasal; Administration, Oral; Animals; Area Under Curve; Biological Availability; Blood Specimen Collection; Chromatography, High Pressure Liquid; Humans; Male; Migraine Disorders; Oxazolidinones; Pyrrolidines; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tryptamines	2017
Outcome for headache and pain-free nonresponders to treatment of the first attack: a pooled post-hoc analysis of four randomized trials of eletriptan 40 mg. Cephalalgia : an international journal of headache, 2014, Volume: 34, Issue:5 Topics: Double-Blind Method; Humans; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2014
Treatment of sinus headache as migraine: the diagnostic utility of triptans. The Laryngoscope, 2008, Volume: 118, Issue:12 Topics: Adult; Aged; Chronic Disease; Diagnosis, Differential; Empiricism; Endoscopy; Female; Follow-Up Studies; Headache; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Prospective Studies; Pyrrolidines; Referral and Consultation; Serotonin Receptor Agonists; Sinusitis; Tomography, X-Ray Computed; Treatment Outcome; Tryptamines	2008
Halide salts of antimigraine agents eletriptan and naratriptan. Acta crystallographica. Section C, Crystal structure communications, 2008, Volume: 64, Issue:Pt 12 Topics: Analgesics; Crystallography, X-Ray; Halogens; Humans; Hydrogen Bonding; Migraine Disorders; Molecular Structure; Piperidines; Pyrrolidines; Salts; Structure-Activity Relationship; Tryptamines	2008
Drug dependence associated with triptans and ergot derivatives: a case/non-case study. European journal of clinical pharmacology, 2010, Volume: 66, Issue:4 Topics: Claviceps; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Risk; Substance-Related Disorders; Sumatriptan; Tryptamines	2010
New medications show promise for migraine sufferers. Dentistry today, 2002, Volume: 21, Issue:10 Topics: Botulinum Toxins, Type A; Carbazoles; Humans; Indoles; Magnesium; Migraine Disorders; Neuromuscular Agents; Phytotherapy; Plant Preparations; Pyrrolidines; Riboflavin; Serotonin Antagonists; Tanacetum parthenium; Tryptamines	2002
Suppression by eletriptan of the activation of trigeminovascular sensory neurons by glyceryl trinitrate. Brain research, 2002, Oct-25, Volume: 953, Issue:1-2 Topics: Animals; Blood Pressure; Cats; Drug Interactions; Electric Stimulation; Electrophysiology; Female; Indoles; Male; Migraine Disorders; Neurons, Afferent; Nitroglycerin; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Trigeminal Caudal Nucleus; Tryptamines; Vasodilation; Vasodilator Agents	2002
Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study. Neurology, 2003, Apr-08, Volume: 60, Issue:7 Topics: Area Under Curve; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Therapeutic Equivalency; Tryptamines; Vasoconstrictor Agents	2003
Eletriptan (relpax) for migraine. The Medical letter on drugs and therapeutics, 2003, Apr-28, Volume: 45, Issue:1155 Topics: Administration, Oral; Biological Availability; Drug Interactions; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Tryptamines	2003
Unilateral time-delayed encapsulation does not make for a fair race. Headache, 2003, Volume: 43, Issue:8 Topics: Capsules; Delayed-Action Preparations; Double-Blind Method; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Research Design; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2003
[Strong and sustained-acting triptan. Therewith migraine does not return soon]. MMW Fortschritte der Medizin, 2003, Aug-07, Volume: 145, Issue:31-32 Topics: Administration, Oral; Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Placebos; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Tryptamines; Vasoconstrictor Agents	2003
Musing on Mathew et al. Headache, 2003, Volume: 43, Issue:8 Topics: Capsules; Clinical Trials as Topic; Double-Blind Method; Humans; Indoles; Migraine Disorders; Prospective Studies; Pyrrolidines; Research Design; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2003
[Improved pharmacokinetics. Fast tryptan with sustained response]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Administration, Oral; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Female; Headache; Humans; Indoles; Male; Migraine Disorders; Oxazolidinones; Piperidines; Placebos; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Tryptamines	2003
[Highly selective beginning. Associated symptoms and side effects in retrospect]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2003
The 40-mg dose of eletriptan: comparative efficacy and tolerability versus sumatriptan 100 mg. European journal of neurology, 2004, Volume: 11, Issue:2 Topics: Adolescent; Adult; Aged; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Odds Ratio; Pyrrolidines; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome; Tryptamines	2004
New drugs 04, part 1. Nursing, 2004, Volume: 34, Issue:2 Topics: Adalimumab; Alefacept; alpha-Galactosidase; Anisoles; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antioxidants; Antiprotozoal Agents; Antirheumatic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Drug Approval; Drug Therapy; Fabry Disease; Gefitinib; Humans; Iduronidase; Indoles; Isoenzymes; Lentigo; Lung Neoplasms; Migraine Disorders; Mucopolysaccharidosis I; Nitro Compounds; Patient Education as Topic; Propylamines; Psoriasis; Pyrrolidines; Quinazolines; Recombinant Fusion Proteins; Serotonin Receptor Agonists; Thiazoles; Tryptamines	2004
TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management. Acta neurologica Scandinavica, 2004, Volume: 110, Issue:3 Topics: Administration, Oral; Adult; Data Collection; Decision Support Techniques; Dose-Response Relationship, Drug; Female; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Patient Satisfaction; Patient Selection; Pyrrolidines; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines	2004
[Use of triptanes according to indications. Risk of infarct is not increased]. MMW Fortschritte der Medizin, 2004, Feb-12, Volume: 146, Issue:7 Topics: Cerebral Infarction; Clinical Trials as Topic; Coronary Circulation; Humans; Indoles; Injections, Intravenous; Injections, Subcutaneous; Migraine Disorders; Myocardial Infarction; Pyrrolidines; Risk; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstriction; Vasoconstrictor Agents	2004
[Spanish contribution to the clinical development of eletriptan: an analysis of controlled studies]. Neurologia (Barcelona, Spain), 2004, Volume: 19, Issue:8 Topics: Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Placebos; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Spain; Treatment Outcome; Tryptamines	2004
Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat. Journal of managed care pharmacy : JMCP, 2005, Volume: 11, Issue:5 Topics: Algorithms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Humans; Managed Care Programs; Migraine Disorders; Piperidines; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines	2005
[Medical treatment of migraine attacks in the child]. Revue de l'infirmiere, 2006, Issue:117 Topics: Acetaminophen; Age Factors; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Child; Ergot Alkaloids; Humans; Ibuprofen; Life Style; Migraine Disorders; Oxazolidinones; Parents; Patient Education as Topic; Pediatrics; Piperidines; Pyrrolidines; Risk Factors; Serotonin Receptor Agonists; Sumatriptan; Taste Disorders; Triazoles; Tryptamines; Vasoconstrictor Agents	2006
Comment on eletriptan in migraine patients reporting unsatisfactory response to rizatriptan. Headache, 2007, Volume: 47, Issue:3 Topics: Humans; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Retreatment; Serotonin Receptor Agonists; Triazoles; Tryptamines	2007
Patient satisfaction with eletriptan in the acute treatment of migraine in primary care. International journal of clinical practice, 2007, Volume: 61, Issue:10 Topics: Acute Disease; Adolescent; Adult; Aged; Family Practice; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Patient Satisfaction; Pyrrolidines; Quality of Life; Serotonin Receptor Agonists; Surveys and Questionnaires; Treatment Outcome; Tryptamines	2007
Identification of negative predictors of pain-free response to triptans: analysis of the eletriptan database. Cephalalgia : an international journal of headache, 2008, Volume: 28, Issue:1 Topics: Adult; Databases, Factual; Double-Blind Method; Female; Humans; Hyperacusis; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Nausea; Pain; Photophobia; Predictive Value of Tests; Pyrrolidines; Randomized Controlled Trials as Topic; Time Factors; Tryptamines	2008
Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database. Headache, 2008, Volume: 48, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Clinical Trials as Topic; Databases, Factual; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Migraine Disorders; Predictive Value of Tests; Pyrrolidines; Randomized Controlled Trials as Topic; Secondary Prevention; Serotonin Receptor Agonists; Sex Factors; Sumatriptan; Tryptamines	2008
Triptans: actions and reactions. Headache, 2008, Volume: 48, Issue:4 Topics: Administration, Cutaneous; Administration, Oral; Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Herpes Simplex; Herpesvirus 2, Human; Humans; Migraine Disorders; Neuralgia, Postherpetic; Pyrrolidines; Serotonin Receptor Agonists; Skin; Sumatriptan; Tryptamines	2008
Porcine carotid vascular effects of eletriptan (UK-116,044): a new 5-HT1B/1D receptor agonist with anti-migraine activity. Naunyn-Schmiedeberg's archives of pharmacology, 1998, Volume: 358, Issue:2 Topics: Animals; Arteriovenous Anastomosis; Blood Flow Velocity; Blood Pressure; Carotid Arteries; Heart Rate; Hemodynamics; Indoles; Jugular Veins; Migraine Disorders; Oxygen Consumption; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Swine; Tryptamines	1998
Migraine revolution and sumatriptan. Lancet (London, England), 2000, Jun-24, Volume: 355, Issue:9222 Topics: Capsules; Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Therapeutic Equivalency; Tryptamines	2000
Electriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan. Neurology, 2000, Sep-12, Volume: 55, Issue:5 Topics: Double-Blind Method; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Research Design; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents	2000
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Neurology, 2000, Sep-12, Volume: 55, Issue:5 Topics: Acute Disease; Double-Blind Method; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents	2000
Effects of eletriptan on the peptidergic innervation of the cerebral dura mater and trigeminal ganglion, and on the expression of c-fos and c-jun in the trigeminal complex of the rat in an experimental migraine model. The European journal of neuroscience, 2000, Volume: 12, Issue:11 Topics: Animals; Axons; Brain; Calcitonin Gene-Related Peptide; Disease Models, Animal; Dura Mater; Female; Gene Expression Regulation; Genes, fos; Genes, jun; Indoles; Male; Migraine Disorders; Neurons, Afferent; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Pyrrolidines; Rats; Rats, Wistar; Serotonin Receptor Agonists; Spinal Cord; Sumatriptan; Trigeminal Ganglion; Tryptamines	2000
Pharmacology and efficacy of eletriptan for the treatment of migraine attacks. International journal of clinical practice, 2000, Volume: 54, Issue:10 Topics: Double-Blind Method; Female; Humans; Indoles; Male; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2000
Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model. Microscopy research and technique, 2001, May-01, Volume: 53, Issue:3 Topics: Animals; Capillaries; Dura Mater; Electric Stimulation; Female; Immunohistochemistry; Indoles; Male; Microscopy, Electron; Migraine Disorders; Nerve Endings; Nerve Fibers; Neuropeptides; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroglycerin; Pyrrolidines; Rats; Rats, Wistar; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Ganglion; Tryptamines; Vasoconstrictor Agents	2001
[Eletriptan shortly before drug approval. Fewer problems in migraine therapy]. MMW Fortschritte der Medizin, 2001, May-28, Volume: 143 Suppl 2 Topics: Dose-Response Relationship, Drug; Drug Approval; Germany; Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2001
Pharmacology and efficacy of eletriptan for the treatment of migraine attacks. International journal of clinical practice, 2001, Volume: 55, Issue:5 Topics: Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2001
[New potent serotonin receptor agonist. Helps migraine patients even when other triptans fail]. MMW Fortschritte der Medizin, 2001, Jul-05, Volume: 143, Issue:26-27 Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2001
[New triptanes in control of migraine attacks. More rapid onset of action--more efficient reduction of pain]. MMW Fortschritte der Medizin, 2002, Jan-24, Volume: 144, Issue:3-4 Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2002
[Migraine has to be treated. Otherwise a stroke threatens]. MMW Fortschritte der Medizin, 2002, Feb-14, Volume: 144, Issue:7 Topics: Humans; Indoles; Migraine Disorders; Pyrrolidines; Risk Factors; Serotonin Receptor Agonists; Stroke; Sumatriptan; Time Factors; Tryptamines	2002